Photopheresis treatment enhances CD95 (fas) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis

被引:0
作者
Aringer, M
Graninger, WB
Smolen, JS
Kiener, HP
Steiner, CW
Trautinger, F
Knobler, R
机构
[1] Univ Vienna, Dept Rheumatol, A-1010 Vienna, Austria
[2] Univ Vienna, Dept Internal Med 4, A-1010 Vienna, Austria
[3] Univ Vienna, Dept Special Dermatol, A-1010 Vienna, Austria
来源
BRITISH JOURNAL OF RHEUMATOLOGY | 1997年 / 36卷 / 12期
关键词
photopheresis; CD95; fas; bcl-2; lymphocytes; systemic sclerosis; apoptosis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the effects of photopheresis in systemic sclerosis by analysing its influence on lymphocytes with regard to apoptosis and expression of bcl-2 and fas. Peripheral blood lymphocytes isolated immediately before and 24 h after photopheresis were investigated for apoptosis, bcl-2 and fas expression by fluorocytometry, and compared to controls. In addition, leucocytes from systemic sclerosis patients taken directly from the photopheresis system were tested for apoptosis after 24 h in culture. fas expression was similar in controls and patients with systemic sclerosis just before photopheresis, but increased 24 h after photopheresis, mainly due to an increase of CD4(+)CD95(+) cells. bcl-2 was overexpressed in scleroderma peripheral lymphocytes, but not influenced by photopheresis. As compared to healthy controls, the percentage of apoptotic cells 24 h after photopheresis was high in cultured lymphocytes, but not es vivo. The significant increase in fas on peripheral lymphocytes observed in this study may be a major operative mechanism of photopheresis in addition to (and possibly related to) the induction of apoptosis.
引用
收藏
页码:1276 / 1282
页数:7
相关论文
共 52 条
[1]   PREDICTORS OF SURVIVAL IN SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
ALTMAN, RD ;
MEDSGER, TA ;
BLOCH, DA ;
MICHEL, BA .
ARTHRITIS AND RHEUMATISM, 1991, 34 (04) :403-413
[2]   PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[3]   HIGH LEVELS OF BCL-2 PROTEIN IN CIRCULATING T-LYMPHOCYTES, BUT NOT B-LYMPHOCYTES, OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ARINGER, M ;
WINTERSBERGER, W ;
STEINER, CW ;
KIENER, H ;
PRESTERL, E ;
JAEGER, U ;
SMOLEN, JS ;
GRANINGER, WB .
ARTHRITIS AND RHEUMATISM, 1994, 37 (10) :1423-1430
[4]   TRIAL OF PLATELET-INHIBITING DRUG IN SCLERODERMA - DOUBLE-BLIND-STUDY WITH DIPYRIDAMOLE AND ASPIRIN [J].
BECKETT, VL ;
CONN, DL ;
FUSTER, V ;
OSMUNDSON, PJ ;
STRONG, CG ;
CHAO, EYS ;
CHESEBRO, JH ;
OFALLON, WM .
ARTHRITIS AND RHEUMATISM, 1984, 27 (10) :1137-1143
[5]  
Boudet F, 1996, J IMMUNOL, V156, P2282
[6]  
Bryan C, 1996, BRIT J RHEUMATOL, V35, P1122
[7]  
Conroy LA, 1996, LEUKEMIA, V10, P1422
[8]   MONOCLONAL-ANTIBODY-MEDIATED APOPTOSIS IN ADULT T-CELL LEUKEMIA [J].
DEBATIN, KM ;
GOLDMANN, CK ;
BAMFORD, R ;
WALDMANN, TA ;
KRAMMER, PH .
LANCET, 1990, 335 (8688) :497-500
[9]   SOLUBLE AND CELLULAR MARKERS OF IMMUNE ACTIVATION IN PATIENTS WITH SYSTEMIC-SCLEROSIS [J].
DEGIANNIS, D ;
SEIBOLD, JR ;
CZARNECKI, M ;
RASKOVA, J ;
RASKA, K .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 56 (02) :259-270
[10]  
DISPALTRO FX, 1993, INT J DERMATOL, V32, P417